Patent · US Active

Influenza B virus mutants and uses therefor

US11529409B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

FluGen, Inc. · US

Inventors

Michael J. Moser · Madison, US
Yasuko Hatta · Madison, US
Pamuk Bilsel · San Diego, US

Key dates

Filing date	Feb 26, 2018
Grant date	Dec 20, 2022
Priority date	—
Expiry date	Feb 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16262
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant BM2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.